Kallo Inc (OTCMKTS:KALO) is holding its gains well after a recent explosion in price and trading volume after the Company announced an update to the previously announced $200 million dollar supply contract in the Republic of Guinea.
When the deal was initially announced back in January of this year the stock exploded from under a nickel to highs of $0.45 per share. Since that time the stock drifted downward hitting a recent low of $0.025. The recent update has brought back excitement to KALO and investors are hoping it can mark a significant reversal.
Kallo Inc (OTCMKTS:KALO) offers a comprehensive healthcare delivery program dedicated to providing the most technologically advanced, innovative healthcare solution that is customized to the requirements of each country, including effective infectious disease management and customized Education and Training programs.
According to the Company’s website they have a Portfolio of Technologies that include:
!ntegraat enables any medical device to connect to any EMR, PACS, HIS, RIS, PIS or DI-r, providing a seamless flow of information and data that ensures clinicians have all the needed information to provide patients timely and effective healthcare.
Kallo MobileCare™ is a comprehensive solution for remote and unreached communities. These mobile clinics are fully equipped with best-in-class medical devices and congruent information systems enabling the centralized coordination of resources and communications through Administration Centres.
Kallo Rural-Care MRHDS are pre-fabricated, pre-tested, modular and project determined medical clinics. They are installed with the latest medical equipment from X-Ray and ultrasound to surgery, lab and pharmacy equipment.
For more info on KALO Please Subscribe below, also you should know we have Something Huge Coming!
CygnaMed™ Globalization, inexpensive travel, high treatment costs, long wait times and lack of access to medical facilities have fuelled Medical Tourism to an approx. $25 billion industry.
oHealth provides the infrastructure, technology, training and support to seamlessly integrate with any clinic, laboratory, specialty, hospital, repository or regional and national Health Information Access Layer (HIAL).
Keristää™ is software developed for the collection, integration and communication of clinical information in emergency conditions. The software enables close and instantaneous monitoring of infectious disease outbreaks.


According to the last 10Q the Company issued ”NOTE 8 – COMMITMENTS AND CONTINGENCIES (continued) Sales commission agreement (continued)
On January 23, 2014, Kallo Inc. announced the signing of a US$200,000,925 Supply Contract with the Ministry of Health and Public Hygiene of the Republic Of Guinea (the “Guinea Project”).
Under the Supply Contract, Kallo will implement customized healthcare delivery solutions for the Republic of Guinea. The components of the solutions include, MobileCare, RuralCare, Hospital Information Systems, Telehealth Systems, Pharmacy Information, disaster management, air and surface patient transportation systems and clinical training.
In respect of the Guinea Project, the Company has agreed with two third parties in Guinea to pay sales commissions for facilitating and securing the Contract with the Ministry of Health of the Republic of Guinea as follows:
$20,000,000, payable as to an advance of $300,000 immediately after the loan agreement for the Kallo MobileCare and RuralCare program is signed by the Minister of Finance of the Republic of Guinea and the remainder within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo.
$4,000,000, payable within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. In addition, a performance incentive payment of $1,000,000 will be payable to three persons related to the third party in accordance to the same terms of payment described herein.
On March 8, 2014, the Company has agreed with a third party to pay sales commissions equal to $25,000,000 for facilitating and securing the Contract with the Government of the Republic of Sierra Leone, payable within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. In addition, an incentive payment of $7,000,000 will also be payable if the Government of Sierra Leone approve the Project on or before August 15, 2014 in accordance to the same terms of payment described above.
Conclusion: KALO has seen a recent explosion in price and volume after the Company re-announced the $200 million dollar supply contract in the Republic of Guinea on November 3; big news for a Company with minimal cash on hand, mounting short term debt and no revenues to date. Besides this the Company burns up to half a million a quarter which has resulted in significant dilution over the years; over the past 3 years KALO O/S has increased from 43 million shares out to current 352 million shares issued and outstanding.
We Have a MASSIVE Stock Pick Coming. You do not want to miss this one!
Currently trading at a 42 million market valuation KALO seems to be benefiting from a growing loyal shareholder base excited over the $200 million deal which may or may not come into fruition. The whole thing sounds kind of crazy honestly. The entire area is right in the middle of the biggest Ebola outbreak in history that is rapidly going out of control. The growing base of excited shareholders is right about one thing though; if the Company actually does receive payment and starts putting out detailed press releases of a real project going forward KALO is liable to go parabolic. Until then, vague updates with basically no information won’t drive the stock anywhere and only drive real investors away. We wait and see…
Disclosure: we hold no position in KALO either long or short and we have not been compensated for this